{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:35:51Z","timestamp":1790562951730,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Paraneoplastic neurological syndromes refer to a group of neurological disorders, which occur as distant effects of malignant tumors and are not caused by metastasis, nutritional disorders, or side effects of antitumor drugs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 70-year-old woman complained of a 1-month history of extremity numbness. Upon presentation to our hospital, she had worsening numbness, and experienced staggering and falling. Physical examination revealed diminished tendon reflexes in both lower limbs, stocking and glove-type abnormal sensation, and left-sided dominant high-steppage gait due to weakness of the bilateral tibialis anterior muscles. Blood tests indicated anemia, and upper gastrointestinal endoscopy revealed gastric cancer, leading to laparoscopic distal gastrectomy. A nerve conduction velocity test showed demyelinating peripheral neuropathy. Further blood tests and imaging studies ruled out nutritional disorders, such as vitamin deficiency, diabetes-related diseases, connective tissue diseases, and central nervous system metastasis, leading to the suspicion of paraneoplastic neurological syndrome. After laparoscopic distal gastrectomy, the progression of symptoms stopped, and with intravenous high-dose immunoglobulin and steroid therapy, the symptoms improved to only minor numbness in the peripheral limbs as of the 18-month follow-up. As of the 2-year follow-up, there has been no cancer recurrence or metastasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>When paraneoplastic neurological syndrome is suspected, early diagnosis and a multidisciplinary approach, including surgical treatment, are important before irreversible neurological damage occurs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-022-01429-2","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T13:07:37Z","timestamp":1651151257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gastric cancer complicated by paraneoplastic neurological syndrome which presented with extremity numbness: a case report"],"prefix":"10.1186","volume":"8","author":[{"given":"Takuto","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Mino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"1429_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0040-6","volume":"14","author":"T Sano","year":"2011","unstructured":"Sano T, Kodera Y. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101\u201312.","journal-title":"Gastric Cancer"},{"key":"1429_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0952-7915(97)80055-6","volume":"5","author":"JB Posner","year":"1997","unstructured":"Posner JB, Dalmaut D. Paraneoplastic syndromes. Curr Opin Immunol. 1997;5:723\u20139.","journal-title":"Curr Opin Immunol"},{"key":"1429_CR3","first-page":"371","volume":"50","author":"K Tanaka","year":"2010","unstructured":"Tanaka K. Paraneoplastic neurological syndromes with reference to anti-neuronal autoantibodies. Clin Neurol. 2010;50:371\u20138.","journal-title":"Clin Neurol"},{"key":"1429_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"1429_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.5692\/clinicalneurol.51.834","volume":"51","author":"T Inuzuka","year":"2011","unstructured":"Inuzuka T, Hayashi Y, Kimura A. Pareneoplastic neurological syndrome\u2013update. Rinsho shinkeigaku = Clin Neurol. 2011;51(11):834\u20137.","journal-title":"Rinsho shinkeigaku = Clin Neurol."},{"key":"1429_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/brain\/111.3.577","volume":"111","author":"JH O\u2019neill","year":"1988","unstructured":"O\u2019neill JH, Murray NMF, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome: a review of 50 cases. Brain. 1988;111:577\u201396. https:\/\/doi.org\/10.1093\/brain\/111.3.577.","journal-title":"Brain"},{"key":"1429_CR7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","volume":"332","author":"VA Lennon","year":"1995","unstructured":"Lennon VA, Kryzer TJ, Griesmann GE, O\u2019Suilleabhain PE, Windebank AJ, Woppmann A, et al. Calcium-channel antibodies in the Lambert\u2013Eaton syndrome and other paraneoplastic syndromes. N Engl J Med. 1995;332:1467\u201375.","journal-title":"N Engl J Med"},{"key":"1429_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0928-4257(93)90022-L","volume":"87","author":"N Martin-Moutot","year":"1993","unstructured":"Martin-Moutot N, el Far O, Leveque C, David P, Marqueze B, Lang B, et al. Synaptotagmin: a Lambert\u2013Eaton myasthenic syndrome antigen that associates with presynaptic calcium channels. J Physiol Paris. 1993;87:37\u201341.","journal-title":"J Physiol Paris"},{"key":"1429_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/jnnp.66.2.214","volume":"66","author":"A Saiz","year":"1999","unstructured":"Saiz A, Dalmau J, Butler MH, Chen Q, Delattre JY, De Camilli P, et al. Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma. J Neurol Neurosurg Psychiatry. 1999;66:214\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1429_CR10","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1136\/jnnp.2003.025171","volume":"75","author":"PM Candler","year":"2004","unstructured":"Candler PM, Hart PE, Barnett M, Weil R, Rees JH. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry. 2004;75:1411\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1429_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12328-012-0328-z","volume":"5","author":"T Taketa","year":"2012","unstructured":"Taketa T, Ohigashi S, Suzuki K, Sudo K, Shiozaki H, Suzuki A, et al. Paraneoplastic neurological syndromes associated with gastric cancer: a case report and review of the literature. J Clin Gastroenterol. 2012;5:355\u201360.","journal-title":"J Clin Gastroenterol"},{"key":"1429_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.20269","volume":"56","author":"SJ Pittock","year":"2004","unstructured":"Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004;56:715\u20139.","journal-title":"Ann Neurol"},{"key":"1429_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/brain\/88.3.427","volume":"88","author":"PB Croft","year":"1965","unstructured":"Croft PB, Wilkson M. The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain. 1965;88:427\u201334. https:\/\/doi.org\/10.1093\/brain\/88.3.427.","journal-title":"Brain"},{"key":"1429_CR14","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","volume":"13","author":"CA Vedeler","year":"2006","unstructured":"Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, Hart IK, et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006;13:682\u201390.","journal-title":"Eur J Neurol"},{"key":"1429_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1191\/0269216303pm758cr","volume":"17","author":"CA Douglas","year":"2003","unstructured":"Douglas CA, Ellershaw J. Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer. Palliat Med. 2003;17:638\u20139.","journal-title":"Palliat Med"},{"key":"1429_CR16","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1212\/WNL.53.8.1719","volume":"53","author":"F Keime-Guibert","year":"1999","unstructured":"Keime-Guibert F, Graus F, Bro\u00ebt P, Re\u00f1\u00e9 R, Molinuevo JL, Ascaso C, et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology. 1999;53:1719\u201323.","journal-title":"Neurology"},{"key":"1429_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","volume":"68","author":"F Keime-Guibert","year":"2000","unstructured":"Keime-Guibert F, Graus F, Fleury A, Ren\u00e9 R, Honnorat J, Broet P, et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry. 2000;68:479\u201382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1429_CR18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/110241599750007766","volume":"165","author":"G Balducci","year":"1999","unstructured":"Balducci G, Frontoni M, Bocchetti T, Angelini D, Di Giacomo G, Ziparo V. Malignant gastric carcinoid and paraneoplastic cerebellar degeneration. Eur J Surg. 1999;165:1193\u20136.","journal-title":"Eur J Surg"},{"key":"1429_CR19","first-page":"104","volume":"91","author":"H Kikuchi","year":"2000","unstructured":"Kikuchi H, Yamada T, Okayama A, Hara H, Taniwaki T, Shigeto H, et al. Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach. Fukuoka Igaku Zasshi. 2000;91:104\u20139.","journal-title":"Fukuoka Igaku Zasshi"},{"key":"1429_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/brain\/124.2.437","volume":"124","author":"L Bataller","year":"2001","unstructured":"Bataller L, Graus F, Saiz A, Vilchez JJ. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001;124:437\u201343.","journal-title":"Brain"},{"key":"1429_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0022-510X(01)00467-1","volume":"185","author":"B Meglic","year":"2001","unstructured":"Meglic B, Graus F, Grad A. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci. 2001;185:135\u20138.","journal-title":"J Neurol Sci"},{"key":"1429_CR22","first-page":"423","volume":"55","author":"Y Wada","year":"2003","unstructured":"Wada Y, Yamamoto T, Kita Y, Fukunishi S, Ashida K. An autopsy case of encephalopathy associated with small cell carcinoma of the stomach with nonconvulsive status epilepticus resembling Creutzfeldt-Jakob disease. No To Shinkei. 2003;55:423\u20138.","journal-title":"No To Shinkei"},{"key":"1429_CR23","first-page":"345","volume":"43","author":"Y Tanaka","year":"2003","unstructured":"Tanaka Y, Nishida H, Yamada O, Takahashi Y, Moriwaki H. Intrathecal glutamate receptor antibodies in a patient with elderly-onset refractory epilepsy. Rinsho Shinkeigaku. 2003;43:345\u20139.","journal-title":"Rinsho Shinkeigaku"},{"key":"1429_CR24","first-page":"144","volume":"46","author":"A Goto","year":"2006","unstructured":"Goto A, Kusumi M, Wakutani Y, Nakaso K, Kowa H, Nakashima K. Anti-Yo antibody associated paraneoplastic cerebellar degeneration with gastric adenocarcinoma in a male patient: a case report. Rinsho Shinkeigaku. 2006;46:144\u20137.","journal-title":"Rinsho Shinkeigaku"},{"key":"1429_CR25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5692\/clinicalneurol.50.246","volume":"50","author":"C Yasuda","year":"2010","unstructured":"Yasuda C, Yakushiji Y, Tokunaga O, Hara H, Nishino I. Case of systemic myositis and subacute sensory neuropathy concomitant with signet-ring cell carcinoma. Rinsho Shinkeigaku. 2010;50:246\u201351.","journal-title":"Rinsho Shinkeigaku"},{"key":"1429_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s10120-010-0563-2","volume":"13","author":"H Murakami","year":"2010","unstructured":"Murakami H, Rino Y, Yamanaka S, Baba Y, Sekiguchi T, Yukawa N, et al. Paraneoplastic neurological syndrome in a patient with gastric cancer. Gastric Cancer. 2010;13:204\u20138.","journal-title":"Gastric Cancer"},{"key":"1429_CR27","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1111\/j.1468-1331.2012.03881.x","volume":"19","author":"D Biotti","year":"2012","unstructured":"Biotti D, Viaccoz A, Olivier N, Tilikete C, Rogemond V, Honnorat J, et al. Opsoclonus, limbic encephalitis, anti-Ma2 antibodies and gastric adenocarcinoma. Eur J Neurol. 2012;19:e144\u20135.","journal-title":"Eur J Neurol"},{"key":"1429_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.hemonc.2014.06.001","volume":"7","author":"T Al-Harbi","year":"2014","unstructured":"Al-Harbi T, Al-Sarawi A, Binfalah M, Dermime S. Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor. Hematol Oncol Stem Cell Ther. 2014;7:116\u20139.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"1429_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/brain\/124.2.437","volume":"124","author":"L Bataller","year":"2001","unstructured":"Bataller L, Graus F, Saiz A, Vilchez JJ. Spanish Opsoclonus-Myoclonus Study Group. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001;124:437\u201343.","journal-title":"Brain"},{"key":"1429_CR30","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.2169\/internalmedicine.55.6917","volume":"55","author":"Y Uneno","year":"2016","unstructured":"Uneno Y, Yokoyama A, Nishikawa Y, Funakoshi T, Ozaki Y, Aoyama I, et al. Paraneoplastic limbic encephalitis in a human epidermal growth factor receptor-2-positive gastric cancer patient treated with trastuzumab-combined chemotherapy: a case report and literature review. Intern Med. 2016;55:2605\u20139.","journal-title":"Intern Med"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-022-01429-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T13:18:48Z","timestamp":1651151928000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-022-01429-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1186\/s40792-022-01429-2","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"6 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"78"}}